Table 2

Summary of costs (NIS at 2010 price levels) and QALY losses of proposed universal GBS screening versus current risk-factor screening
Incremental
Current Proposed Change
Screening Costs 617,408 3,498,644 2,881,236
Treatment Savings –614,683 –2,550,420 –1,935,737
lifetime productivity gains –256,990 –1,068,618 –811,628
Net Cost to Society –254,266 –120,394 133,872
Mortality QALYs lost 34.97 23.87 –11.10
Morbidity QALYs lost 0.56 0.24 –0.32
Sequellae QALYs lost 1.97 0.81 –1.16
Total QALYS lost 37.50 24.92 –12.58

Ginsberg et al.

Ginsberg et al. Israel Journal of Health Policy Research 2013 2:6   doi:10.1186/2045-4015-2-6

Open Data